He also refused to elaborate, and actually avoided the question about competition, but lauded the safety of MSC technology.
We already know that, from the Companies that have done testing on naturally derived MSC's, and are near to approval.
What KK failed to discuss was the "ugly" term, reproducing artificial cells, or reproducing cells artificially for the greenies.
The question remains the same about manufactured cells in vitro attempted replication.
It is simply many years away to prove that science when the FDA are just getting their head around the benefits of naturally derived cell technology, or should I say the worlds demand for it already.
- Forums
- ASX - By Stock
- Ann: Sharewise Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

He also refused to elaborate, and actually avoided the question...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 88474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 0.165 |
1 | 30000 | 0.160 |
4 | 66451 | 0.155 |
5 | 136673 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 88474 | 2 |
0.175 | 77450 | 2 |
0.180 | 113494 | 5 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |